The research was conducted in Lalmonirhat and Thakurgaon districts during 2020–2021. Researchers assessed participants at baseline, trained them in enhanced self-care and then followed them after three months, with final assessments conducted at six months in Lalmonirhat and nine months in Thakurgaon. The measures included lymphoedema stage, acute attacks, pain, adherence and costs for self-care items such as soap, cream and pain relief. The baseline population covered the full severity range represented in the two districts, although the proportions with mild, moderate and severe disease varied: mild cases accounted for 11.2–54.7%, moderate cases 21.9–39.5% and severe cases 23.4–49.3%.

Before training, acute attacks and severe pain were widespread. Across the district and follow-up ranges, 62.8–79.6% of participants reported acute attacks and 40.6–54.6% reported severe pain. After the enhanced protocol, the corresponding ranges were 25.2–35.2% and 22.4–28.0%, respectively. These are reported longitudinal associations rather than proof of a causal effect. The study followed one cohort of people affected by filarial lymphoedema, used self-reported clinical outcomes and provided different final observation periods for the two districts, limiting how broadly the results can be generalized.

The study also found that self-care imposed a continuing out-of-pocket burden. Baseline monthly expenditure for participants’ self-care items ranged from 195.3 to 215.2 Bangladeshi taka, equivalent to US$2.29–2.53 in the source report. People with severe lymphoedema spent significantly more each month than those with mild disease in both districts: averages were 234.3 versus 159.2 BDT in Lalmonirhat and 234.2 versus 172.0 BDT in Thakurgaon, with both p-values below 0.05. Total monthly spending remained broadly stable over time, but its composition changed significantly, with spending shifting toward soap and cream and expenditure on pain relief decreasing, at p<0.001. Exploratory mixed-effects analyses found that higher expenditure was independently associated with follow-up time, district and greater baseline lymphoedema severity. Taken together, the results indicate that enhanced self-care training was associated with fewer reported acute attacks and less severe pain, while the financial burden of home care persisted, especially among participants with severe disease.

Subject of Research: Clinical outcomes and household costs of enhanced lymphoedema self-care in Bangladesh

Article Title: Evaluating the cost of self-care: Impact of enhanced morbidity management protocol on people living with lymphatic filariasis in Bangladesh

Article References: Williams, T., Karim, M. J., Siddiqui, S., Fazlur Rahman, A., Chowdhury, S., Jahan, S., AMS, S. M., Forbes, S. P., Betts, H., Taylor, M. J., & Kelly-Hope, L. A. (2026). Evaluating the cost of self-care: Impact of enhanced morbidity management protocol on people living with lymphatic filariasis in Bangladesh. PLOS Neglected Tropical Diseases, 20(10), e0014812. https://doi.org/10.1371/journal.pntd.0014812

Image Credits: AI Generated

DOI: 10.1371/journal.pntd.0014812

Keywords: lymphatic filariasis, lymphoedema, self-care training, Bangladesh, acute attacks, chronic pain, healthcare costs, out-of-pocket spending, longitudinal cohort, morbidity management, Evaluating, cost

The correspondence, published on 16 September 2026, responds directly to the CaRe feasibility study, a head and neck cancer rehabilitation trial published earlier in the same journal in June 2026 by Sheill and colleagues. Feasibility studies occupy a crucial niche in clinical research. They test whether a trial can actually be done: whether patients will enrol, whether clinicians can deliver the intervention consistently, whether outcome measures are tolerable and interpretable, and whether attrition stays within acceptable limits. The CaRe study did exactly this work for a structured rehabilitation programme in head and neck cancer, laying the groundwork that larger definitive trials require.

Yet Abou-Bakr and Hassanein contend that a trial can pass every feasibility benchmark and still fail to answer the questions that matter most to patients, if it treats all head and neck cancer survivors as a single homogeneous group. Their central argument is that lymphoedema is not a minor comorbidity to be averaged out in randomisation; it is a distinct clinical entity that changes what rehabilitation should look like, what outcomes are realistic, and how success should be measured. Pooling patients with and without lymphoedema, they suggest, risks diluting treatment effects and obscuring the very signals that a definitive trial is designed to detect.

The clinical case for stratification rests on a growing body of evidence about what head and neck lymphoedema actually does to patients. A 2026 systematic review by Gaitatzis and colleagues in the Journal of Cancer Survivorship examined patient-reported outcome measures and physical function following head and neck lymphoedema and documented the breadth of its impact. Unlike limb lymphoedema, which is visible and relatively straightforward to measure with circumference or volume techniques, lymphoedema in the head and neck region affects structures that govern speech, swallowing, breathing, and appearance. Internal lymphoedema, involving the pharynx and larynx, can be invisible from the outside while profoundly impairing function.

The burden extends well beyond physical symptoms. Research by Starmer and colleagues, published in Supportive Care in Cancer in 2023, captured the patient perspective on head and neck lymphoedema and quality of life, revealing how swelling reshapes identity, social interaction, and emotional wellbeing. A 2024 study by Arends and colleagues in the journal Cancers added further weight, showing that lymphoedema and trismus, the restriction of jaw opening that frequently accompanies treatment, have a measurable impact on body image and quality of life after head and neck cancer. For a population already coping with disfigurement, altered speech, and compromised swallowing, lymphoedema compounds the challenge of returning to a recognisable life.

Against this backdrop, the evidence base for treating head and neck lymphoedema remains strikingly thin. A 2025 systematic review by de-la-Cruz-Fernández and colleagues in Supportive Care in Cancer assessed randomised controlled trials of physical therapy interventions for lymphoedema management in this population and found the available trials limited in number and scope. This scarcity is precisely why feasibility work such as the CaRe study matters, and equally why the field cannot afford to design its definitive trials carelessly. If the few large trials that eventually emerge fail to account for lymphoedema status, an entire generation of rehabilitation evidence may be built on foundations too heterogeneous to support firm conclusions.

The argument for lymphoedema-stratified trial design has technical dimensions that go beyond simple subgroup analysis. Stratification in randomised trials means that patients are grouped by a key prognostic characteristic before randomisation, ensuring that treatment and control arms are balanced for that characteristic. In the context of head and neck cancer rehabilitation, stratifying by lymphoedema presence, severity, or type, external versus internal, would allow investigators to estimate whether rehabilitation produces different benefits in patients whose lymphatic systems have been compromised. It would also permit pre-specified subgroup analyses that are powered and planned from the outset, rather than the underpowered post hoc explorations that have historically plagued rehabilitation research.

Measurement is another pillar of the argument. Trials that ignore lymphoedema may choose outcome instruments that are insensitive to the changes that matter most to affected patients. The systematic review by Gaitatzis and colleagues highlighted the state of patient-reported outcome measures in this space, and the correspondence implicitly raises the question of whether generic quality-of-life instruments can capture the specific distress of facial and neck swelling, or whether lymphoedema-specific measures should be embedded in trial design. A rehabilitation programme might improve general physical function while leaving a patient’s lymphoedema-related body image concerns untouched, a result that a poorly designed trial would misread as partial success rather than a targeted failure.

The broader context of head and neck cancer survivorship strengthens the case further. Studies of rehabilitation needs, including work by Karampela and colleagues published in Frontiers in Oncology in 2021, have documented gaps between what patients require and what services deliver, while a 2025 systematic review by Bernstein and colleagues catalogued the social impacts of treatment and rehabilitation in this population. Head and neck cancer survivors face some of the highest rates of depression, social withdrawal, and functional impairment in oncology, and rehabilitation is the discipline charged with restoring what treatment takes away. Designing rehabilitation trials that reflect the true clinical heterogeneity of the population is therefore not a methodological nicety; it is a prerequisite for evidence that translates into meaningful care.

Abou-Bakr and Hassanein’s correspondence, written without specific funding and with no declared competing interests, functions as a call to action for trialists in supportive and rehabilitative cancer care. The message is that the field has demonstrated it can run rehabilitation studies in head and neck cancer; the CaRe feasibility study and its predecessors have answered the operational questions. The next step demands more ambition: definitive trials in which lymphoedema is not an afterthought but a design principle, with stratified randomisation, lymphoedema-sensitive outcome measures, and analyses planned to reveal which patients benefit most from which interventions. For the growing population of head and neck cancer survivors living with swelling that affects how they speak, swallow, and see themselves in the mirror, the difference between a generic rehabilitation trial and a lymphoedema-stratified one could ultimately determine whether the evidence that guides their care is sharp enough to help them.

Subject of Research: Lymphoedema-stratified rehabilitation trial design in head and neck cancer survivorship

Article Title: Beyond feasibility: the case for lymphoedema-stratified rehabilitation trials in head and neck cancer

Article References: Abou-Bakr, A., & Hassanein, F. E. A. (2026). Beyond feasibility: the case for lymphoedema-stratified rehabilitation trials in head and neck cancer. Supportive Care in Cancer, 34(10), Article 977. https://doi.org/10.1007/s00520-026-11222-8

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11222-8

Keywords: head and neck cancer, lymphoedema, cancer rehabilitation, clinical trial design, stratification, feasibility study, quality of life, supportive care, physical therapy, trismus, patient-reported outcomes, cancer survivorship

Lymphoedema is a persistent swelling, most often in an arm or a leg, that develops when the lymphatic system is damaged or disrupted, commonly as a side effect of cancer surgery or radiotherapy. Once lymph nodes have been removed or irradiated, the affected limb can struggle to drain lymph fluid efficiently, leading to heaviness, discomfort, reduced mobility and, in some cases, recurrent infections. For decades, patients were told to rest the affected limb and avoid resistance exercise, on the fear that increased blood flow and muscle activity might overwhelm the compromised drainage pathways and worsen the swelling.

That conservative wisdom has been steadily overturned over the past fifteen years. Landmark trials, including a well-known study of weight lifting in women with breast-cancer-related lymphoedema published in the New England Journal of Medicine, demonstrated that progressive resistance training, when properly supervised, did not exacerbate the condition and could even reduce symptoms. Subsequent studies of aquatic exercise, complex rehabilitation programmes and home-based regimens have reinforced the message that exercise is not only safe for many lymphoedema patients but potentially therapeutic, improving strength, function and quality of life.

What remained uncertain was whether such programmes could be delivered entirely remotely, a question that became urgent during the COVID-19 pandemic and has stayed relevant as telehealth reshapes rehabilitation medicine. The new study, conducted as part of the CAN-React Study at the University of Galway, set out to test the feasibility of a ten-week individualised exercise programme in which every element, from baseline testing to supervised online sessions, took place without a single in-person visit. The work was led by Yanxue Lian and Ananya Gupta of the Discipline of Physiology at University of Galway, with colleagues from University Hospital Galway and the Discipline of Surgery.

The researchers recruited 27 cancer survivors with unilateral lymphoedema, meaning the swelling affected one limb. Nineteen participants had upper-body lymphoedema, typically following breast cancer treatment, while eight had lower-body lymphoedema, more commonly associated with gynaecological and other pelvic cancers. Before the programme began, each participant completed a fully supervised remote assessment battery covering lymphoedema severity alongside five domains of physical fitness: cardiorespiratory capacity, muscular strength, balance, flexibility and mobility. The same assessments were repeated after the ten-week intervention, allowing the team to explore preliminary changes over time.

The exercise prescription itself was individualised, tailored to each participant’s baseline fitness, limitations and lymphoedema status, and delivered through weekly supervised online exercise sessions supplemented by prescribed home exercises to be performed independently. This hybrid structure reflects a growing recognition in rehabilitation science that supervised sessions build confidence, correct technique and sustain motivation, while home practice drives the volume of activity needed to produce physiological adaptation. Digital and remote delivery models have previously been shown in systematic reviews to improve adherence to home exercise rehabilitation, one of the most stubborn challenges in the field, and the Galway team’s results add weight to that evidence.

On the primary question of feasibility, the findings were strongly positive. Overall programme completion was 81.5 percent, a high figure for a ten-week exercise intervention in a clinical population. Adherence to the weekly supervised online sessions exceeded 80 percent, and participants self-reported completing roughly 75 percent of their prescribed home exercises. Safety was equally reassuring: of the five participants who withdrew, all had upper-body lymphoedema, and only one withdrawal was linked to a medical event, an unrelated infection and lumbar vertebral abscess that the investigators judged to be unrelated to the intervention. No other adverse events were reported across the cohort, meaning no participant experienced an exercise-related worsening of their lymphoedema.

The exploratory outcomes, though preliminary and not powered to confirm efficacy, pointed in a promising direction. Analyses suggested potential improvements across multiple domains of physical fitness, including cardiorespiratory capacity, muscular strength, flexibility and balance, alongside reductions in lymphoedema severity. For patients, these are the outcomes that matter most: a stronger, more mobile body and a limb that feels and functions better. The consistency of improvement across such a broad fitness profile suggests that the individualised prescription approach, which adapts training to each person’s deficits, may be a sensible way to structure remote rehabilitation, though the authors and the field at large will need larger controlled trials to confirm these signals.

The technical achievement of conducting fitness assessments entirely at a distance deserves particular attention. Measuring muscular strength, balance, flexibility and mobility without an examiner in the room raises legitimate questions about reliability, and researchers in geriatrics and physiotherapy have only recently begun validating remote test protocols against in-person administration. Studies of remote physical function assessment in older adults and of telehealth-adapted strength and mobility tests for people with dementia have reported encouraging agreement with face-to-face measurement, and the Galway team’s successful completion of remote baseline and post-intervention testing in a lymphoedema population extends this emerging methodology to a new clinical group. Self-measurement of limb volume, a cornerstone of lymphoedema monitoring, has also been shown in prior validation work to be feasible and reliable when patients are properly instructed, which underpins the credibility of the severity data collected at home.

The implications reach beyond lymphoedema. Cancer survivorship care is grappling with how to deliver exercise medicine, now widely regarded as a core component of supportive care, to the growing population of survivors, many of whom live far from specialist centres or face fatigue, transport and scheduling barriers. A model that combines remote supervised sessions with individualised home programming, delivered safely even to patients with a condition as delicate as lymphoedema, could be adapted to many other survivor groups. The study was supported by an Athena Swan Capacity Building and career development grant from the National University of Ireland, Galway, and received ethical approval from the Clinical Research Ethics Committee of University Hospital Galway. The authors are careful to frame the work as a feasibility pilot rather than a definitive trial, and the small sample size and lack of a control group mean the fitness and lymphoedema improvements must be treated as hypothesis-generating. Even so, the core message is clear and striking: with proper supervision and personalisation, cancer survivors with lymphoedema can exercise safely at home, stick with the programme at high rates, and may come out the other side fitter and less swollen than when they started.

Subject of Research: Remote home-based personalised exercise rehabilitation for cancer survivors with lymphoedema

Article Title: Feasibility of a remote and home-based personalised exercise programme in cancer survivors with lymphoedema

Article References: Lian, Y., Kenny, G., Chew, S., Kerin, M., & Gupta, A. (2026). Feasibility of a remote and home-based personalised exercise programme in cancer survivors with lymphoedema. Supportive Care in Cancer, 34(10), Article 988. https://doi.org/10.1007/s00520-026-11210-y

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11210-y

Keywords: cancer survivorship, lymphoedema, remote exercise, telehealth, physical fitness, rehabilitation, breast cancer, home-based exercise, feasibility study, adherence, supportive care, personalised medicine

Podoconiosis, the disease at the heart of the research, is a non-infectious neglected tropical disease characterized by progressive swelling of the lower limbs, lesions, and nodular growths. It develops when irritant mineral particles in alkaline red clay soil penetrate bare skin over years of exposure, triggering chronic inflammation and non-filarial lymphoedema. The condition disproportionately affects subsistence farmers in low-income regions of Africa, Central and South America, and Southeast Asia who work barefoot with limited access to water. Beyond its physical toll, podoconiosis carries heavy social costs, including stigma, psychological distress, reduced economic productivity, and social exclusion that trap affected households in cycles of poverty. Across sub-Saharan Africa, the disease remains endemic in twelve countries, with the highest prevalences reported in Cameroon at 8.1 percent, Ethiopia at 7.5 percent, Uganda at 4.5 percent, and Kenya at 3.9 percent. Rwanda reports a national prevalence of 68.5 cases per 100,000 people, and women are twice as likely to be affected as men.

The scientific case for footwear as prevention is well established. Shoes and socks form a physical barrier that reduces contact with irritant soil particles, and to be effective the footwear must cover both the soles and the tops of the feet while withstanding labor that increases soil exposure. In Europe and North Africa, behavior change communication combined with increased shoe-wearing contributed to the elimination of podoconiosis decades ago. In Ethiopia, organizations such as Mossy Foot International have established workshops that manufacture and distribute more than 400 pairs of shoes monthly, improving shoe-wearing behavior and case management in endemic communities. Yet in Rwanda, national prevention strategies have primarily emphasized community education about the benefits of wearing shoes, an approach that earlier research suggested was insufficient on its own. Protective footwear at local markets is often expensive and unaffordable for high-risk populations, suitable options are scarce in village stores, and consistent shoe-wearing is constrained by a complex interplay of gender norms, power dynamics, and community backlash. Women’s limited control over household finances and decision-making further hinders rural female farmers from purchasing and wearing boots.

To address these barriers, a research team from the University of Global Health Equity partnered with Heart and Sole Africa, a community-based organization providing podoconiosis care in Rwanda, and DuHope, a Community Benefit Company that equips Rwandan women leaving sex work with job skills and employment. Guided by gender transformative approaches and a Target Product Profile framework, which outlines preferred product specifications before development based on the needs of the target population, the collaboration set out to test a culturally and ergonomically acceptable boot prototype built from previously identified farmer preferences. DuHope analyzed locally available raw materials, developed six prototypes, and subjected them to iterative testing and modification before a final design balancing functionality, design, and cost was approved for production by a local manufacturer.

The resulting boot was a waterproof rubber design available in green, black, and blue. It stood mid-calf in height, featured grooved soles for traction, and included a soft padded inner sock that could be washed and dried within an hour. The top of the boot was open and laced, allowing wearers to adjust the fit to their preference. In a deliberate nod to aesthetics and identity, the top edge was lined with kitenge fabric matching the traditional and daily attire of rural women, covered with transparent plastic to ease cleaning and enhance durability. The design details mattered: women in earlier assessments had reported that boots felt like garments meant for men, and the team hoped a visibly women-centered product could begin to dismantle that perception.

Boots were distributed to 148 rural farmers, 110 women and 38 men, living in the four cells with the highest podoconiosis prevalence across Rwanda’s provinces, in the districts of Nyamasheke, Musanze, Nyagatare, and Nyaruguru. Participants were asked to wear the prototypes daily during farming, household chores, market trips, and other regular activities while noting their observations. The distribution was paired with community education campaigns covering the causes, management, and prevention of podoconiosis, as well as gender norms and myths associated with boots. Participants also received empowerment materials, including bracelets inscribed with the Kinyarwanda slogan “Ibirenge Bizima,” meaning Fit Feet, and a comic book narrating a female protagonist’s journey of learning about a mysterious disease that caused her friend’s feet to swell. After a one-month trial, the team conducted sixteen audio-recorded focus group discussions with the farmers to explore their experiences.

The results were striking. Farmers reported that receiving the boots and engaging with the education campaign encouraged more consistent shoe-wearing, and participants living with podoconiosis perceived meaningful improvements in their symptoms, including reduced swelling and itching and an improved ability to wear normal shoes. One woman in Nyagatare recounted visiting a clinic where staff exclaimed that her podoconiosis appeared cured, and replying that it was because of the boots. Mindsets shifted as well: women who had once believed boots were only for men came to see them as protective equipment for everyone, and some male participants testified that the change inspired other women in their communities to buy and wear boots without fear of judgment. The boots were perceived as comfortable and versatile, suitable for farming, rearing livestock, fetching water, and going to the market, although a few participants noted they remained inappropriate for social occasions such as weddings or church because of the outfits worn at those events. A long-standing fear that boots would damage crops also eroded under the weight of personal experience, though some farmers still removed them during certain harvesting tasks.

Yet the study does not shy away from the social friction the boots generated. Persistent stereotypes labeled women who wore boots as disrespectful, confused them with agronomists, or assumed they were rich simply because they owned a pair, and one woman reported that wearing the boots made it harder to find casual farming work. Some men initially viewed women in boots as overstepping gender boundaries, and older women in particular described feeling intimidated by the prospect of being seen in footwear that conflicted with dominant cultural norms. Some farmers who wore the boots in public were even labeled as diseased or disabled, a reaction the researchers attribute to the boots being distributed to a subset of the community and to their unfamiliar design. Crucially, however, most female farmers reported that these norms and reactions did not deter them from wearing the boots while farming, because they understood the protective value. Many turned mockery into an opportunity to educate their neighbors about podoconiosis prevention, reframing the footwear from a symbol of illness into one of protection. Support from husbands, local leaders, and peers reinforced their resolve, and one district official’s endorsement of women wearing boots as a sign of development validated female farmers and fostered positive community attitudes.

The authors argue that these findings carry important lessons for Rwanda’s 2030 goal of eliminating podoconiosis through scaled-up integrated clinical services and locally driven solutions. Combining education with boot distribution mirrors successful approaches elsewhere, such as western Uganda, where pairing footwear distribution with culturally tailored education increased shoe-wearing by 25 percent, and Ethiopia, where more than 77 percent of individuals with podoconiosis reported reduced swelling after consistent footwear use. The study also demonstrates that participatory, gender transformative design can foster empowerment and challenge power imbalances, but that such changes are gradual and require broader efforts to address structural and economic barriers. The researchers caution that footwear interventions can unintentionally reinforce disease-related labels when they target only a subset of the population, and they recommend pairing future scale-up with community-wide sensitization and distribution approaches that avoid singling out specific groups. Limitations include the short one-month trial period, the absence of clinical testing of the boots’ effectiveness against disease progression, the free distribution of the prototypes, and the potential influence of the Hawthorne effect, since farmers knew they would later evaluate the footwear. Even so, the study stands as a compelling demonstration that equitable access to protective footwear, treated as a public health priority and grounded in the lived experiences of at-risk communities, can transform both disease prevention and the social fabric of the villages where it is needed most.

Subject of Research: Testing a co-designed protective farming boot to prevent podoconiosis among rural female farmers in Rwanda

Article Title: “My feet are no longer swollen”: Testing a co-designed podoconiosis protective footwear among rural female farmers in Rwanda

Article References: Igihozo, G., Dusabe, L., Uwizeyimana, J., Boiles, J., Huston, T., & Schurer, J. M. (2026). “My feet are no longer swollen”: Testing a co-designed podoconiosis protective footwear among rural female farmers in Rwanda. PLOS Global Public Health, 6(10), e0007114. https://doi.org/10.1371/journal.pgph.0007114

Image Credits: AI Generated

DOI: 10.1371/journal.pgph.0007114

Keywords: podoconiosis, neglected tropical diseases, Rwanda, protective footwear, gender norms, community-based participatory research, women farmers, lymphoedema, soil exposure, public health, stigma, footwear design

Cellulitis is a bacterial infection of the skin and the soft tissue beneath it, most often caused by streptococci or staphylococci that slip through cracks in the skin’s protective barrier. The result is a red, hot, swollen and painful area of skin, usually on the lower legs, often accompanied by fever and malaise. Although antibiotics can usually clear the infection, cellulitis imposes a substantial burden on health systems, because severe cases require intravenous therapy and hospital admission, and a considerable share of patients return with new episodes months or years later. Despite how frequently clinicians encounter the disease, risk factors reported in the literature have been inconsistent, which is precisely the gap the Vienna team set out to close.

The researchers designed their investigation as a retrospective case-control study, a design that compares people who have a condition with people who do not, and then looks backward to identify exposures or characteristics that differ between the two groups. In this case, the cases were 1,395 patients treated for cellulitis, while the controls numbered 667. Using regression models, the team analyzed which variables were associated with three distinct outcomes: the initial development of cellulitis, the occurrence of recurrent episodes, and prolonged hospitalization. Statistical models of this kind produce odds ratios, figures that express how much more likely an outcome is in the presence of a given factor, together with confidence intervals that indicate the precision of the estimate and p-values that signal statistical significance.

The results paint a remarkably consistent picture. Male sex emerged as a strong risk factor for developing cellulitis in the first place, with an odds ratio of 2.68, meaning men in the dataset had nearly triple the odds of women. Higher baseline age also mattered, with each additional year of age modestly but significantly raising the odds, reflected in an odds ratio of 1.03 per year. These demographic findings align with the clinical intuition that older patients and male patients are overrepresented on wards treating soft tissue infections, but the study places those impressions on firm quantitative footing.

The most striking findings concerned breaches of the skin barrier, which dwarfed every other risk factor in magnitude. Patients with tinea pedis, the fungal infection commonly known as athlete’s foot, had an odds ratio of 72.48 for developing cellulitis, an enormous effect that underscores how the fissures and scaling produced by a seemingly minor fungal problem can open the door to serious bacterial invasion. Ulcers carried an odds ratio of 45.79, traumatic wounds an odds ratio of 229.26, stasis dermatitis an odds ratio of 10.81, and eczema an odds ratio of 13.14. In other words, almost any condition that compromises the integrity of the skin, whether through inflammation, ulceration or injury, dramatically multiplies the risk that bacteria will gain entry and establish an infection in the underlying tissue.

Fluid-related conditions formed a second major cluster of risk. Venous insufficiency, in which faulty valves in the leg veins allow blood to pool and fluid to leak into the tissues, was associated with an odds ratio of 2.36. Lymphoedema, the swelling that results from impaired drainage of lymph fluid, carried an odds ratio of 11.21, and oedema not otherwise specified an odds ratio of 13.12. The biological logic is compelling: fluid-rich, swollen tissue is thought to impair local immune defenses and circulation, creating an environment in which bacteria that have breached the skin can proliferate more easily. Clinicians have long observed that patients with chronically swollen legs are prone to cellulitis, and this study quantifies just how pronounced that vulnerability is.

Metabolic and chronic systemic conditions also left their mark. Diabetes mellitus was associated with an odds ratio of 1.58 for disease onset, chronic kidney disease with an odds ratio of 2.29, and obesity with an odds ratio of 2.74. Each of these conditions is known to affect immunity, tissue perfusion or wound healing in ways that could plausibly facilitate infection. Diabetes impairs both immune cell function and microvascular circulation, chronic kidney disease is linked to immune dysfunction and fluid overload, and obesity is associated with chronic low-grade inflammation, altered lymphatic drainage and skin fold problems that can compromise the barrier function of the skin.

Perhaps the most clinically consequential finding is that obesity did not merely raise the risk of a first episode. It was also a consistent risk factor for multiple disease episodes, with an odds ratio of 1.73, and for prolonged hospitalization, with an odds ratio of 1.72. This means that patients with obesity were not only more likely to develop cellulitis in the first place but also more likely to experience the disease repeatedly and to require longer hospital stays when they did. In an era when obesity rates continue to climb globally, this finding suggests that the burden of cellulitis on health systems may grow in parallel, and it highlights weight management as a potential long-term strategy for reducing both the incidence and the severity of the disease.

The authors conclude that male sex, higher age, breaches of the skin barrier, oedema, diabetes mellitus, chronic kidney disease and obesity may act as strong risk factors for cellulitis, with obesity additionally predisposing patients to recurrent episodes and extended hospitalization. The practical implications are significant. For patients with athlete’s foot, ulcers, eczema or leg swelling, meticulous skin care and prompt treatment of these conditions could represent a highly effective form of prevention, given the enormous odds ratios attached to barrier defects. For patients with lymphoedema or venous insufficiency, compression therapy and careful management of swelling may reduce infection risk. And for the growing population of patients with obesity, the study adds another compelling reason to address weight as a modifiable factor in infectious disease risk.

As with any retrospective case-control study, the findings describe associations rather than proven causal relationships, and the retrospective design means the researchers relied on previously recorded data rather than prospective observation. Nevertheless, the large number of patients analyzed and the breadth of risk factors examined make this one of the most comprehensive assessments of cellulitis epidemiology available. By systematically separating the factors that drive the first infection from those that drive recurrence and prolonged hospital stay, the Vienna team has given clinicians a clearer map of where to focus preventive efforts, from treating fungal foot infections and managing leg swelling to recognizing obesity as a factor that shapes the entire trajectory of this common and costly infection.

Subject of Research: Risk factors for the onset, recurrence and prolonged hospitalization of cellulitis patients

Article Title: Risk factors for onset, recurrence and prolonged hospitalization in patients with cellulitis: a retrospective case-control study

Article References: Borst, C., Steiner, I., Stegmüller, S., Peichl, D., Egger, E., Symmank, D., Chromy, D., & Weninger, W. (2026). Risk factors for onset, recurrence and prolonged hospitalization in patients with cellulitis: a retrospective case-control study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14500-2

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14500-2

Keywords: cellulitis, skin infection, risk factors, obesity, tinea pedis, lymphoedema, diabetes mellitus, chronic kidney disease, case-control study, hospitalization, dermatology, infectious diseases